Lockdown Medical Limited continues to be a British privately owned company, with a rich history of product development and innovation.
LockDown Medical, Ltd. has over 30 years heritage in developing industry defining medical devices that are first of their kind and have clinical longevity.
Constantly innovating to bring you the most advanced medical solutions.
Your needs are central to us, and we collaborate extensively to ensure they are met.
Committed to maintaining the highest ethical standards in all our interactions with you.
Delivering you services and support that adhere to the highest quality standards.
Lockdown Medical’s journey began in 1924 with A.W. Showell Ltd., a maker of haberdashery needles. The company evolved, eventually founding Lockdown Medical in 1993 to provide innovative orthopaedic products. It initially focused on trauma and rehab braces, before introducing the integrated interbody technology platform known as STALIF, alongside innovative devices like the LOM™ Lateral Ankle Brace and the ProGlider™ Walker.
Throughout its history, Lockdown Medical has upheld a commitment to quality and innovation, continually expanding its product range to serve the orthopaedic community.
Currently, our core product Lockdown LSSS™, is a double braided augmentation device, designed to provide fixation during the healing process following an acromioclavicular separation due to coracoclavicular ligament disruption.
With over 2,000 implantations globally every year, the Lockdown LSSS™ device offers excellent clinical results and patient satisfaction outcomes. A simple, reproducible surgical procedure requires no holes in the coracoid and a fast rehabilitation process.
The patient’s arm is supported by a sling at 2 weeks post operatively, and the most exacting activities (including contact sports) can be resumed after 12 weeks. The Lockdown LSSS™ device is CE marked and gained FDA approval for use in February 2011.
Lockdown Medical Ltd currently distributes products to Australia, Ireland, Israel, Italy, Netherlands, Malaysia, Scandinavia, South Africa, UAE and the USA. We are currently seeking other distribution partners around the world. See our full distributor list here.
“Many surgeons first try LockDown as an alternative to other options and continue to use it because it works, the technique is quick, straightforward, reproducible and consistently delivers reliable results with an extremely low failure rate. Additionally, LockDown is versatile, making it suitable for both acute and chronic cases in one procedure and does not come with the complications commonly associated with other devices or techniques.”
“It is with much enthusiasm I am writing to support the inclusion of the Lockdown Shoulder Stabilisation System within our product basket offering to the South African Market.
The first case was done in October 2013, and now 11 years later we have established the Lockdown as the “go-to” for ACJ dislocations. The straight-forward surgical technique, reproducible results and early patient mobilisation allow an easy return to life, which contribute to its continued success in this competitive market. The strength of the Lockdown, with load to failure of 1730N, makes it the clear leader.
We find that we also have a useful revision market established by failed competitor product surgeries.”
“One of my patients recently described the LockDown procedure as life-changing for her dislocated acromioclavicular joint. At just four weeks post-op, she’s off her sling and back to daily activities, eager to return to Pilates and the gym. This aligns with my decade-long experience using LockDown – when applied to the right cases, it truly makes a remarkable difference in recovery and quality of life.”
“LockDown™ was first introduced as a method of addressing failed ACJ surgery and this was how I was introduced to the technique. It has since gained popularity as a primary method of stabilizing the disrupted ACJ and I have routinely used it as my first choice for ACJ reconstruction for over 6 years.”
“The operation was very straightforward and I left hospital the following morning in a sling but my range of motion was back straight away. I think the best recommendation I can give for this product, and the confidence I now have, is that prior to the injury I wore shoulder protection and for the past four years, since recovering from the surgery, I have not worn any.”
“The operation was without incident and I was up and about within hours.
I started my rehabilitation with light mobilisation physio and was back in training after 12 weeks. Not only would I recommend the procedure to another player but if I injured my other shoulder I would have the same operation without any hesitation. My shoulder has never been an issue in training or when out on the field at Club or International level”
Discover the future of ACJ treatment with LockDown’s advanced solutions. Share your details below to learn how our LSSS system can enhance your surgical practice in soft tissue reconstruction.
LockDown Medical Limited
16 The Oaks, Clews Road, Redditch, Worcestershire B98 7ST
United Kingdom
We are registered with BSI and hold Certificate no. MD 534510 and operate a Quality Management System which complies with the requirements of ISO 13485:2016.
We are registered with the FDA in the USA, Registration no. 8020712 FEI No. 3008237817.
Our products are CE-marked Certificate No. CE 00403.
Our VAT number is 933 8359 95.
Website designed and produced by marketing agency Creative Tweed.
